LONDON/ HELSINKI, Dec 18- Two of Europe's top three remaining telecommunications equipment companies, Nokia Networks and Alcatel-Lucent, have revived talks on a possible merger, Germany's Manager Magazin reported on Thursday, citing company sources. Shares in Alcatel rose 8 percent following the report. Alcatel-Lucent and Nokia have held on-again,...» Read More
Goodman Fielder said it has received a A$1.3 billion ($1.2 billion) bid from Wilmar International but that the offer undervalues the company.
General Electric is in talks with Alstom to take over its global power business. A deal could be announced in days, two sources said.
Medical device maker Zimmer Holdings said it would buy orthopedic products company Biomet to broaden its portfolio of products that treat bone and joint-related disorders.
Drugmakers eager to satisfy shareholders are wheeling, dealing, and in one case even making trades like a pro sports team looking to shake up its roster.
Comcast may divest about 4 million subscribers after its merger with Time Warner Cable and may sell a portion to Charter Communications.
CNBC's Patti Domm discusses the amount of merger activity happening this week with a big three-way deal in the drug industry, and the $46 billion bid by Valeant and activist Bill Ackman for Allergan.
Walgreen's pending acquisition of Alliance Boots can mean lower taxes and a better company, according to activist investor Barry Rosenstein.
"Shark Tank" investor Kevin O'Leary discusses recent mergers between pharmaceutical companies.
Valeant Pharmaceuticals and Bill Ackman are proposing a cash-and-stock deal for Allergan that could be worth about $45 billion.
Netflix announced it intends to raise its membership price for new subscribers, and Netflix CEO Reed Hastings remarked on the proposed Comcast and Time Warner Cable deal during the webcast, with the "Squawk Box" crew.
Pharmaceutical industry observers have been waiting for a rush of deals for months - and they might have finally arrived.
CNBC's Catherine Boyle discusses reports that U.S. drugmaker Pfizer held informal talks with pharmaceutical firm AstraZeneca about a takeover bid.
John Sculley, former Apple CEO and Managing Partner at Inflexionpoint, expects Alibaba to push on with its buying spree after listing in the U.S.
Global drinks firm Diageo on Tuesday announced the launch of a tender offer to acquire up to 26 percent more in India's United Spirits.
Former Time Warner CEO Gerald Levin, gives his strong support for the merger between Comcast and Time Warner Cable. Right now we're in an explosion of programming. Let these companies have the opportunity to create new businesses, says Levin.
South African retailer Woolworths Holdings is set to buy Australia's second-largest department store David Jones for $2 billion,.
Michael Carr, Goldman Sachs M&A group in the Americas, shares his thoughts on the role of activists in deal making and the outlook for mergers and acquisitions.
Activism in the long-term is not only bad for shareholders but also bad for the economy as a whole, says Martin Lipton, Wachtell, Lipton, Rosen & Katz, expressing his views on shareholder activism. Also Lipton shares his thoughts on the two categories of hedge fund activism.
It's been a robust 12 months of mergers and buyouts. Here's an inside look at four high-profile deals from Facebook-WhatsApp to Warren Buffett's involvement with Heinz.
Facebook's buy of virtual reality headset maker Oculus is prompting some to wonder if CEO Zuckerberg is already living in an alternate reality.